Indefinite Delivery Contract 36E79720D0067
Award Date
10/8/20
Last Date to Order
10/7/25
Federal Agency
National Acquisition Center
Awardee
Pfizer Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This Indefinite Delivery Contract (IDC) was awarded by the National Acquisition Center, a civilian agency of the U.S. federal government, to Pfizer Inc. as the prime contractor. The contract has a total ceiling value of $83,732,812.80 and a period of performance from September 15, 2020 to September 14, 2025, including a base year and four one-year option periods. The purpose of this IDC is to procure rituximab vials for the Department of Veterans Affairs, Department of Defense, Bureau of...
This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), a civilian federal agency, to Pfizer Inc., a large pharmaceutical manufacturer, on June 1, 2025. The $458,750,000 multiple-award contract has an ultimate completion date of May 31, 2026 and is for the procurement of adult COVID-19 vaccines. As a prime contractor, Pfizer will be responsible for supplying the CDC's Pittsburgh location with the necessary COVID-19 vaccine products over the...
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Pfizer Inc., a global pharmaceutical manufacturer, to provide COVID-19 pediatric vaccines. The contract has a ceiling value of $1,096,801,491.00 and a period of performance running through September 30, 2025. As the prime contractor, Pfizer will deliver a range of critical pharmaceutical products to support various federal healthcare programs, including the Vaccines for Children (VFC)...
The provided information describes an Indefinite Delivery Contract (IDC) awarded by the Centers for Disease Control and Prevention (CDC) to Pfizer Inc., a leading global pharmaceutical corporation. The $425.5 million IDC, with a period of performance running from June 2023 to June 2024, is for the procurement of adult COVID-19 vaccines. As a major supplier of pharmaceutical products and vaccines to the U.S. federal government, Pfizer holds several significant Indefinite Delivery Vehicles (IDVs),...
This Indefinite Delivery Contract (IDC) with a ceiling value of $347,200,000.00 was awarded to Pfizer Inc. on June 1, 2024 by the Centers for Disease Control and Prevention (CDC) to provide COVID-19 adult vaccines. The contract has a period of performance through September 30, 2025 and was awarded without any set-aside designation, reflecting Pfizer's status as a large pharmaceutical corporation. Under this IDC, Pfizer will supply a variety of adult vaccines to support the CDC's public health...
This Federal Supply Schedule contract, awarded by the Department of Veterans Affairs to Pfizer Inc., a large pharmaceutical manufacturer, provides a $7.31 billion ceiling for the delivery of drugs, pharmaceuticals, and hematology-related products to federal agencies. The contract has an ultimate completion date of June 30, 2029. Under this IDV, a $2,151,230 firm fixed-price delivery order was issued by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, to...
This is a single-award Indefinite Delivery Contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Pfizer Inc., a large pharmaceutical corporation. The contract has a ceiling value of $48,683,160.88 and an ultimate completion date of August 31, 2030. Pfizer is tasked with delivering a wide range of critical pharmaceutical products to support various federal healthcare programs and agencies, including the Department of Veterans Affairs, Department of Defense, Bureau of...
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Pfizer Inc., a large pharmaceutical manufacturer, for the procurement of pediatric COVID-19 vaccines. The contract has a total ceiling value of $1,009,243,769 and a period of performance from June 1, 2025, through May 31, 2026. The primary objective of this IDC is to provide the CDC with a reliable source for pediatric COVID-19 vaccines to support the Vaccines for Children (VFC)...
This Indefinite Delivery Contract (IDC) was awarded by the National Acquisition Center, a civilian agency, to Pfizer Inc. to provide an uninterrupted supply of Bevacizumab (ZIRABEV) for the Department of Veterans Affairs (VA), Department of Defense (DoD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The contract has a 1-year base period with four 1-year option periods, for a total potential period of performance through August 12, 2025. The contract value has a ceiling of...
The U.S. Defense Logistics Agency Troop Support Medical awarded a single-award Indefinite Delivery Contract (IDC) to Pfizer Inc. to supply a wide range of pharmaceutical products, including prescription medications, vaccines, and other critical medical supplies to support various government healthcare initiatives. The $10 million IDC has an ultimate completion date of December 18, 2024 and was originally procured through a competitive solicitation that sought proposals to establish multiple...